Catalyst Wire Dossier Catalyst Wire Dossier

Enzalutamide

enzalutamide · Pfizer
Drug timelines are a Plus or Pro feature.

130 regulatory and trial events tracked for Enzalutamide, covering 2013-07-30 to 2026-04-27. Get the full timeline:

Most recent: Clinical Trial Update: This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve. [Phase 3]

See pricing